Question 1

Who is Barry E. Greene?

Accepted Answer

Barry E. Greene serves as Executive at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have executed 185 insider transactions totaling $63.5M over their tenure at the company.

Question 2

What is Barry E. Greene's role at ALNYLAM PHARMACEUTICALS, INC.?

Accepted Answer

Barry E. Greene holds the position of Executive at ALNYLAM PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.

Question 3

Is Barry E. Greene buying or selling ALNY stock?

Accepted Answer

Barry E. Greene has shown a selling trading pattern, with $2.1M in total purchases and $61.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.

Question 4

What are Barry E. Greene's largest insider transactions?

Accepted Answer

The largest transaction by Barry E. Greene was on Aug 13, 2008, when they sold $1.0M worth of ALNY shares. This transaction involved 30,889 shares at $33.94 per share.

Question 5

What is Barry E. Greene's trading accuracy?

Accepted Answer

Barry E. Greene has a Personal Accuracy Score of 89/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is Barry E. Greene associated with?

Accepted Answer

Barry E. Greene has filed Form 4 transactions for 1 different company. Their primary association is with ALNYLAM PHARMACEUTICALS, INC. (ALNY), where they serve as Executive.

Question 7

How much ALNY stock does Barry E. Greene own?

Accepted Answer

Barry E. Greene currently owns 97,340 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is Barry E. Greene's equity in ALNYLAM PHARMACEUTICALS, INC.?

Accepted Answer

Barry E. Greene's equity position in ALNYLAM PHARMACEUTICALS, INC. consists of 97,340 shares valued at approximately $0. As Executive, they have executed 185 insider transactions, with $2.1M in purchases and $61.3M in sales.

Question 9

Where can I find Barry E. Greene's SEC Form 4 filings?

Accepted Answer

All of Barry E. Greene's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Barry E. Greene has 185 Form 4 filings on record as an insider at ALNYLAM PHARMACEUTICALS, INC..

Question 10

What is Barry E. Greene's net worth from ALNY?

Accepted Answer

Based on their current ALNY stock holdings, Barry E. Greene has equity worth approximately $0 in ALNYLAM PHARMACEUTICALS, INC.. This value is based on 97,340 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Dec 12, 2011	ALNY	$5.0K	Purchase	699	$7.15	Discretionary
Nov 14, 2011	ALNY	$5.0K	Purchase	704

Barry E. Greene

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

Barry E. Greene Trading Summary

How Much ALNY Stock Does Barry E. Greene Own?

Is Barry E. Greene Buying or Selling ALNY?

Barry E. Greene's Recent Stock Transactions

Frequently Asked Questions

Track Barry E. Greene's Trades